Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch

Go back to Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
LIGAND PHARMA (NASDAQ: LGND) Delayed: 312.37 +2.01 (0.65%)
Previous Close $310.36    52 Week High $139.79 
Open $310.52    52 Week Low $82.07 
Day High $317.23    P/E 726.44 
Day Low $306.95    EPS $0.43 
Volume 500,757